Tag: HEA BIO MTC PHA AFI

Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody

MIDDLETOWN, Del., July 10, 2025 /PRNewswire/ -- Earendil Labs, an AI-empowered biotechnology company, announced that it has completed cohort 1 dosing in a phase...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsHEA BIO MTC PHA AFI

Natural Grocers® Supports Regional American Red Cross Flood Relief Efforts by Collecting Donations at All Texas Stores

ROSEN, LEADING INVESTOR COUNSEL, Encourages iRobot Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – IRBT

TEM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action...

Tag: HEA BIO MTC PHA AFI

Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us